A new study finds that patients' perception of their general health improves after receiving prosthodontic treatment, adding more shine to the prospect of such treatment among some patients. German ...
Sixteen percent (16%) of patients with castration-resistant prostate cancer (CRPC) show no bone metastasis at diagnosis. However, 33% will become metastatic within 2 years. The goal of treatment in ...
The clinical and radiographic examinations of edentulous patients generally occur during an assessment of the need for prostheses. The most common pathological conditions detected are impacted teeth and retained roots with and without associated disease.51 Other less common conditions also may be detected: bony spicules along the alveolar ridge ...
It can pose a barrier to seeking and entering treatment and perpetuate stigma and shame at treatment setbacks. By the same token, reduction of substance use has important public health benefits as well as clinical benefits for patients, and recognition of this could greatly advance medication development for treatment of addiction and its symptoms.
Most patients are diagnosed at a far less treatable, later stage of the disease. And with about 20% of lung cancer deaths preventable, evidence-based screening recommendations for high-risk patients offer the best hope to catch the disease early and provide the best chance for effective treatment. A medical oncologist shares more.
ascopubs.org: Identifying patient profiles and mapping treatment journeys of ARPI-treated, taxane-naive patients with metastatic prostate cancer across three countries in a digital patient ...
Identifying patient profiles and mapping treatment journeys of ARPI-treated, taxane-naive patients with metastatic prostate cancer across three countries in a digital patient ...